Episurf Medical Update: US Regulatory Path
Episurf Medical commenced internal actions to select its regulatory pathway for application for U.S. market acceptance. A decision is expected by 3Q17. May 15, 2017
OrthAlign Receives Japan Approval for Direct Anterior HipAlign and UniAlign
OrthAlign received Japan regulatory approval to market Direct Anterior HipAlign® for use in supine position THA and UniAlign™ for UKA, to be distributed by Zimmer Biomet Japan. May 15, 2017
Curasan Launches CERASORB Ortho Foam in the US
CURASAN entered the U.S. market with the first U.S. implantation of CERASORB® Ortho Foam bone graft. May 15, 2017
Vertebral Technologies Granted Patent for Modular Device Design
Vertebral Technologies received notice of allowance for its patent, "Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices." May 11, 2017
Intrinsic Therapeutics Closes $49MM Financing
Intrinsic Therapeutics closed a US $49MM round of financing, which will support global commercialization of the Barricaid Anular Closure Device. May 10, 2017
Providence Medical Technology Secures New $10.5MM Financing
Providence Medical Technology closed a US $10.5MM debt agreement that will support distribution of cervical fusion technology in U.S. and ex-U.S. markets. May 10, 2017
Vericel Licenses Products for Distribution in Southeast Asia
Vericel entered into a license agreement whereby Innovative Cellular Therapeutics will obtain exclusive rights to develop and distribute Carticel® and MACI® in Southeast Asia. May 10, 2017
Cook Medical Divests Vertebroplasty Products
Cook Medical sold its vertebroplasty product line to IZI Medical Products. May 10, 2017
Carmell Therapeutics to Launch Phase III Study of Bone Healing Accelerant
Carmell Therapeutics will launch a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material product/indication, designed to treat fractures. May 09, 2017
Aesculap Implant Systems Presents Long-term activL Study Data
Studies indicate that, at 5 years, the activ-L® Artificial Disc from Aesculap Implant Systems had a protective effect on the progression of degenerative disc disease at adjacent levels in 91.2% of patients. May 09, 2017
